#RA pattern of synovitis is well knownn & decr in grip strength seen in Early (39%) & later RA (59% @5y). MCP1 synovitis impacts grip strength most (60%) followed by MCP4 (much less w/ tender/swelling of PIPs,other MCPs). Based on study of 215 early RA pts https://t.co/rTFBHKlNGV https://t.co/zCVsTNuYWW

ARCTIC Rewind: Three-Year Data in RA https://t.co/ls2e3LtlvK https://t.co/FtgSq713rc

Rheum Fellowship Slots Fill Up for 2024 The NRMP announced yesterday that the 2024 rheumatology fellowship match filled 97.6% (124/127) of programs, and 98.9% (273/276) of rheumatology fellowship positions. https://t.co/wTwajHyal0 https://t.co/JpgDUmioQh

Early bird pricing has been extended! Register today! https://t.co/wuvDqE0Qe6 https://t.co/8XXcQUBK6G https://t.co/ISRYMVdRfr

What do you think of the concept of "dysuricemia" - the concept that both hyperuricemia and hypouricemia influence diseases. “The lower, the better” is incorrect; the ideal is to maintain normouricemia, or optimal SU level, to reduce the urate burden https://t.co/vYSNzWuPVW https://t.co/tde3Mh6Wij

Do We Stop or Continue Treatment? Remission had been a dream, an elusive concept. But then, with the introduction of biologics, conventional synthetic and targeted synthetic DMARDS, patients are able to live longer and with a better quality of life. https://t.co/2ecihSwGIV https://t.co/rAjHvlyMB8

WATCH: TMP SMX Prophylaxis in GPA https://t.co/VEkGFUewjG https://t.co/HouepsLEuw https://t.co/r1kiXejFQn

The SMART Study: Split Dose Oral Methotrexate Dr. Jack Cush discusses abstract 1583 presented at the 2023 ACR Convergence meeting in San Diego. https://t.co/STybvwt9N5 https://t.co/BTwstJiFHr https://t.co/vfb2A5zZAp

Biologics as First-line Therapy for PMR and GCA? Dr. Eric Dein talks with Dr. Philip Seo, one of two panelists for the Great Debate: Should PMR and GCA Be Treated with Advanced Therapies at Disease Onset? https://t.co/eezZkBr8x7 https://t.co/D0dTSkjsNS https://t.co/nBlFyKNkHM

Can Rheumatologists Accurately Diagnose axSpA in Patients w/Chronic Back Pain? Chronic low back pain is a common complaint that patients bring to the doctor’s attention. https://t.co/dnlRtjsUHl https://t.co/wQq1J4Iudf https://t.co/24dQSWlwdr

"Protein kinases: drug targets for immunological disorders". Great full-read review from J Shea et al. Reviews Hx, biology, clinical use and safetey of Kinase targeted therapy. https://t.co/T4qMZG2DLI https://t.co/xANcLeiGr6 https://t.co/wAknXuvjl4

Check out this engaging video exploring the pathophysiology and management of gout flares. https://t.co/wgxUIkdJ7v https://t.co/kWRGXfPeYz